Summary & Overview
CPT 95070: Bronchial Challenge Test, Technical Component
CPT code 95070 represents the technical component of a bronchial challenge test (histamine or methacholine challenge) used to evaluate airway hyperresponsiveness and assist in diagnosing asthma. As a technical-only code, 95070 covers the performance, monitoring, and data acquisition aspects of the provocation test rather than physician interpretation. This code is relevant nationally for hospital outpatient departments, pulmonary function laboratories, and ambulatory diagnostic clinics that perform pulmonary provocation testing.
Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical context for the test, typical sites of service, and an explanation of the technical-versus-professional component distinction. The publication covers billing benchmarks and payer policy considerations where available, common modifier usage scenarios, and implications for coding workflows in pulmonary diagnostic services.
The document is intended to help coding professionals, revenue cycle staff, and clinical administrators understand the purpose of CPT code 95070, how it fits into the diagnostic pathway for suspected asthma, and what topics to review when aligning billing practices with payer policies. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 95070 describes the technical component of a bronchial challenge test, also known as a histamine challenge test or methacholine challenge test, used to assist in the diagnosis of asthma. The service involves administration of an inhaled test substance in a controlled sequence to assess airway hyperresponsiveness.
Service type: Pulmonary function provocation testing (technical component only)
Typical site of service: Hospital outpatient departments, pulmonary function laboratories, or ambulatory care clinics where pulmonary diagnostic testing is performed.
Clinical & Coding Specifications
Clinical Context
A 28-year-old adult presents to the pulmonary function laboratory with a history of episodic wheeze, cough, and exertional shortness of breath. Baseline spirometry demonstrates normal or borderline airways function but symptoms and history raise concern for bronchial hyperresponsiveness and possible asthma. The clinician elects to perform a bronchial challenge test (methacholine or histamine challenge) to assess airway reactivity. The patient discontinues bronchodilators per protocol before arrival. In the pulmonary function lab, a respiratory therapist or trained technologist administers incremental concentrations of the inhaled challenge agent while the provider monitors spirometry (FEV1) and patient safety. The test's technical component includes preparing and delivering the test solution, conducting timed inhalations, measuring spirometric responses, and documenting objective pulmonary function results. Typical sites of service are the hospital outpatient department or an independent pulmonary function laboratory within an ambulatory care center. The typical patient scenario involves pretest screening for contraindications, serial spirometry during graded exposures, and post-test monitoring until FEV1 returns to baseline or bronchodilator reversal is provided as needed. Billing reflects the technical component of the bronchial challenge test as 95070 (technical component only).
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when reporting the physician’s interpretation and report separate from the technical component. |
TC | Technical component | Use to report the technical portion only (equipment, technologist) as in 95070. |
59 | Distinct procedural service | Use when a separate, distinct procedure is performed on the same day and not normally reported together. |
52 | Reduced services | Use when the test is partially completed or limited in scope and full testing cannot be performed. |
53 | Discontinued procedure | Use when the challenge test is started but halted for patient safety or other valid reasons. |
76 | Repeat procedure by same physician | Use when the same procedure is repeated later the same day by the same provider (note: 76 is not in provided list; not applicable). |
78 | Unplanned return to the operating/procedure room by the same physician following initial procedure for a related procedure during the postoperative period | Rarely applicable; use only if an unplanned therapeutic intervention in a procedure setting occurs. |
80 | Assistant surgeon | Not typically applicable to bronchial challenge testing; include only if an assistant role is billed. |
QX | CRNA service with medical direction by anesthesiologist | Use when CRNA credentials and medical direction apply (rare for PFT lab). |
XE | Separate encounter, distinct from the overlapping service | Use when services are performed on separate encounters by the same provider but require separation for billing. |
XU | Unusual non-overlapping services | Use when the service is distinct and unrelated to other services billed for the same day. |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
| 207RC0000X | Pulmonology | Pulmonologists commonly interpret and order bronchial challenge testing. |
| 2084P0800X | Allergy & Immunology | Allergists often perform or order bronchial provocation testing as part of asthma evaluation. |
| 363L00000X | Respiratory Therapy | Respiratory therapists and PFT technologists perform the technical components in the lab. |
| 207K00000X | Internal Medicine | Hospital-based internists may order and interpret testing in outpatient settings. |
| 208200000X | Pediatrics | Pediatric pulmonologists perform methacholine challenges in children when indicated. |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
J45.909 | Unspecified asthma, uncomplicated | Common indication to evaluate for airway hyperresponsiveness when baseline testing is inconclusive. |
R06.2 | Wheezing | Symptom prompting bronchial provocation testing to assess reversible airway obstruction. |
R05 | Cough | Persistent cough with suspected asthma may prompt methacholine challenge. |
J98.01 | Acute bronchospasm | Used when bronchospasm is documented or provoked during testing; relevant for monitoring and intervention. |
R06.0 | Dyspnea | Exertional or unexplained dyspnea may lead to bronchial challenge to evaluate for asthma-related causes. |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
94010 | Bronchospasm evaluation; spirometry, including graphic record, total and timed vital capacity, expiratory flow rates | Baseline and post-challenge spirometry performed before and during the bronchial challenge test to document FEV1 changes. |
94375 | Bronchial provocation tests, non-specific bronchoprovocation (eg, methacholine), spirometry | Used for reporting bronchial provocation testing including administration and spirometric measurements; may be used instead of or alongside 95070 depending on component reporting. |
94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction; multiple activities | May be billed if bronchodilator therapy is administered during or after testing to reverse bronchospasm. |
99070 | Supplies and materials (eg, drugs, biologicals), provided by the physician over and above those usually included with the office visit or other services rendered | Used to report special challenge agents or disposables supplied by the facility/provider for the test. |
99406 | Smoking and tobacco use cessation counseling visit, intermediate, greater than 3 minutes up to 10 minutes | Counseling services related to smoking cessation may be provided during the same encounter when relevant to pulmonary evaluation. |